Biotech · Private company
LigaChem Biosciences, Inc.
Track this companyFree. Adds LigaChem Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Anti-PD-1 monoclonal antibodyPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- LCB02APhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- LCB84Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- LNCB74Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Oct 14, 2026ClinicalTrials.gov NCT07460375 · fetched Nov 12, 2026
- A Phase 1 Study of LNCB74 in Advanced Solid TumorsPHASE1 · RECRUITING · started Jan 7, 2025ClinicalTrials.gov NCT06774963 · fetched Nov 12, 2026
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Oct 5, 2023ClinicalTrials.gov NCT05941507 · fetched Nov 12, 2026